30 leading drug companies to set 240 billion won of R&D budget.

30 leading domestic drug companies allocated 6% of their sales revenue to the R&D budget this year, about 20% up from the previous year, implying an aggressive attempt to leap into the advanced country, a survey unveiled.

The survey disclosed on May 17 showed that the total sales amount generated by 30 leading companies this year estimated to 4,056,900 million won, 5.89% (238,900 million won...